NCT07309263

Brief Summary

As health awareness continues to rise, more people are prioritizing exercise to improve physical condition and enhance overall fitness. For those lacking exercise habits, selecting a simple, accessible, and effective workout becomes crucial. Against a backdrop of prolonged sitting and inactivity, "super slow jogging" is gaining attention. This aerobic exercise involves a slow walking pace and low intensity, yet burns more calories than regular walking, making it an ideal entry-level activity for beginners or those with lower fitness levels. This study aims to investigate whether incorporating super slow jogging training can effectively enhance cardiorespiratory fitness and respiratory function, comparing its outcomes with other exercise types. The purpose of this experiment is academic research, primarily exploring the impact of exercise intervention on physiological functions. It is not intended for health screening or medical diagnosis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2025

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

November 21, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 30, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2026

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
Last Updated

December 30, 2025

Status Verified

August 1, 2025

Enrollment Period

2 months

First QC Date

November 21, 2025

Last Update Submit

December 29, 2025

Conditions

Outcome Measures

Primary Outcomes (11)

  • Cardiopulmonary Fitness

    VO2max (ml/kg/mL)

    Before intervention and the end of intervention at 12 weeks

  • Baseline anthropometric of the participants

    Age (yr)

    Before intervention and the end of intervention at 12 weeks

  • Cardiopulmonary Fitness

    VEmax (L/min)

    Before intervention and the end of intervention at 12 weeks

  • Cardiopulmonary Fitness

    AT% (%VO₂max)

    Before intervention and the end of intervention at 12 weeks

  • Cardiopulmonary Fitness

    Resting O₂ pulse (mL·beat-¹)

    Before intervention and the end of intervention at 12 weeks

  • Cardiopulmonary Fitness

    Max O₂ pulse (mL·beat-¹)

    Before intervention and the end of intervention at 12 weeks

  • Cardiopulmonary Fitness

    MIP (cmH2O)

    Before intervention and the end of intervention at 12 weeks

  • Cardiopulmonary Fitness

    MEP (cmH2O)

    Before intervention and the end of intervention at 12 weeks

  • Baseline anthropometric of the participants

    Height (cm)

    Before intervention and the end of intervention at 12 weeks

  • Baseline anthropometric of the participants

    Weight (kg)

    Before intervention and the end of intervention at 12 weeks

  • Baseline anthropometric of the participants

    BMI (kg/m²)

    Before intervention and the end of intervention at 12 weeks

Secondary Outcomes (8)

  • Lung function

    Before intervention and the end of intervention at 12 weeks

  • Lung function

    Before intervention and the end of intervention at 12 weeks

  • Lung function

    Before intervention and the end of intervention at 12 weeks

  • Lung function

    Before intervention and the end of intervention at 12 weeks

  • Lung function

    Before intervention and the end of intervention at 12 weeks

  • +3 more secondary outcomes

Study Arms (3)

Super slow jogging

EXPERIMENTAL

A smart app will provide pacing assistance, adjusting step frequency weekly: Week 1: 150 steps per minute Week 2: 180 steps per minute Week 3: 190 steps per minute Week 4: 200 steps per minute

Behavioral: Super slow jogging

moderate exercise training

EXPERIMENTAL

Continuous cycling training at moderate intensity of 60% VO₂max

Behavioral: moderate exercise training

Control

PLACEBO COMPARATOR

not perform any exercise training

Behavioral: Control

Interventions

ControlBEHAVIORAL

This study is a randomized controlled trial employing simple randomization, where participants draw lots to assign groups. The experiment comprises three groups: the super-slow jogging group, the stationary bicycle group, and the control group. Both exercise intervention groups underwent 50-minute training sessions comprising a 10-minute warm-up, 30-minute main exercise, and 10-minute cool-down. Super-Slow Jogging Group: Utilized a smart app for pacing assistance, adjusting step frequency weekly: Week 1: 150 steps/minute Week 2: 180 steps/minute Week 3: 190 steps/minute Week 4: 200 steps/minute Stationary Cycling Group: Participants will engage in continuous cycling training at moderate intensity (60% VO₂max). Control Group: No exercise training intervention.

Control

This study is a randomized controlled trial employing simple randomization, where participants draw lots to assign groups. The experiment comprises three groups: the super-slow jogging group, the stationary bicycle group, and the control group. Both exercise intervention groups underwent 50-minute training sessions comprising a 10-minute warm-up, 30-minute main exercise, and 10-minute cool-down. Super-Slow Jogging Group: Utilized a smart app for pacing assistance, adjusting step frequency weekly: Week 1: 150 steps/minute Week 2: 180 steps/minute Week 3: 190 steps/minute Week 4: 200 steps/minute Stationary Cycling Group: Participants will engage in continuous cycling training at moderate intensity (60% VO₂max). Control Group: No exercise training intervention.

Super slow jogging

This study is a randomized controlled trial employing simple randomization, where participants draw lots to assign groups. The experiment comprises three groups: the super-slow jogging group, the stationary bicycle group, and the control group. Both exercise intervention groups underwent 50-minute training sessions comprising a 10-minute warm-up, 30-minute main exercise, and 10-minute cool-down. Super-Slow Jogging Group: Utilized a smart app for pacing assistance, adjusting step frequency weekly: Week 1: 150 steps/minute Week 2: 180 steps/minute Week 3: 190 steps/minute Week 4: 200 steps/minute Stationary Cycling Group: Participants will engage in continuous cycling training at moderate intensity (60% VO₂max). Control Group: No exercise training intervention.

moderate exercise training

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • required no regular exercise training in the past six months
  • ability to safely perform high-intensity cycling exercise

You may not qualify if:

  • musculoskeletal limitations that prevented cycling exercise
  • recent infection
  • known cardiopulmonary disease or medical history affecting cardiovascular or respiratory function
  • smoking
  • use of medications that may influence cardiopulmonary responses to exercise
  • other contraindications to exercise testing according to the American College of Sports Medicine (ACSM) guidelines

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

No. 151, Jinxue Rd.

Kaohsiung City, Daliao, 831301, Taiwan

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 21, 2025

First Posted

December 30, 2025

Study Start

November 20, 2025

Primary Completion

January 31, 2026

Study Completion

February 28, 2026

Last Updated

December 30, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations